Английская Википедия:Elafibranor

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Elafibranor (INN,[1] code name GFT505) is an experimental medication that is being studied and developed by Genfit for the treatment of cardiometabolic diseases including diabetes, insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD).[2][3][4]

Elafibranor is a dual PPARα/δ agonist.[5][6]

See also

References

Шаблон:Reflist

External links

Шаблон:PPAR modulators

Шаблон:Gastrointestinal-drug-stub